Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients.
about
Anti-angiogenic agents in metastatic colorectal cancerApproaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).Emergence of Chinese drug discovery research: impact of hit and lead identification.Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22.Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes.Famitinib exerted powerful antitumor activity in human gastric cancer cells and xenografts.Biomedical importance of indoles.Biotransformation and bioactivation reactions - 2016 literature highlights.Novel anti-angiogenic therapeutic strategies in colorectal cancer.Azoreductases in drug metabolism.Characterization of an epoxide-derived metabolite of dictamnine using high-performance liquid chromatography with hybrid linear trap quadrupole orbitrap mass spectrometry.Phase I study of the safety, pharmacokinetics and antitumor activity of famitinib.Interspecies metabolic diversity of harmaline and harmine in in vitro 11 mammalian liver microsomes.Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial.Metabolic Profiling of the Novel Hypoxia-Inducible Factor 2α Inhibitor PT2385 In Vivo and In Vitro.A dual substrate kinetic model for cytochrome P450BM3-F87G catalysis: simultaneous binding of long chain aldehydes and 4-fluorophenol.Metabolism and Bioactivation of Fluorochloridone, a Novel Selective Herbicide, in Vivo and in Vitro.Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS).Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.Role of Cytochrome P450 Enzymes in the Metabolic Activation of Tyrosine Kinase Inhibitors
P2860
Q26801911-3F9E387A-C779-4595-B48A-E075028DF470Q30244676-117E2989-B5F8-497E-931C-5D30CD674272Q34553148-6136529C-3025-465F-8BB1-40D65DE89C35Q35529100-68C02D43-305E-472C-AD24-2F06FD29653BQ36197829-9892C69A-7C50-4FDA-BC16-EA9FEFA18AAEQ36653901-DF94A5AA-BAF7-4FBF-8C91-1E633DE97299Q37146958-80740780-71A2-4717-A292-88045783C899Q37204806-DFC71D90-7DD9-4B3D-8F44-DE036762EA62Q38112598-A77CB7A7-6A2E-45E7-BDD5-116AD353D5FCQ38688045-0EF39C93-3C5D-4204-9B3F-6E06D55196AEQ38759141-384F821A-A025-4659-8D4B-6BBA8FAF21D3Q38917152-312EC85E-3CAC-47EC-9954-D5CFB6EA42B3Q39240054-6FE9DD00-FDCC-472C-A97D-300F03A21C7FQ39348852-64490E62-64B0-41E6-91EC-DA2BF949CE33Q46523170-938064E5-2AC0-4D04-BD37-7BBA9345C6DFQ47104695-CF7FAF13-7D14-4569-ACD9-2F9730F17463Q49832801-3B8B8E0D-1B8C-4658-83B8-9E4E8F8EC902Q51058608-0088E8CE-BE5D-4FCD-ACEE-F8AFF650676DQ53057886-0FDEFF48-0A1D-4D8C-B01C-6A22C2F13F3DQ54660067-2FED8310-2733-47E3-92E1-6E6142B7AACAQ54977664-2697EE84-D4EC-4732-8211-01C07ACD02A2Q58788266-789677F4-DB7E-48CB-B799-BB60FED92A85
P2860
Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Metabolism and bioactivation o ...... ne kinase, in cancer patients.
@ast
Metabolism and bioactivation o ...... ne kinase, in cancer patients.
@en
type
label
Metabolism and bioactivation o ...... ne kinase, in cancer patients.
@ast
Metabolism and bioactivation o ...... ne kinase, in cancer patients.
@en
prefLabel
Metabolism and bioactivation o ...... ne kinase, in cancer patients.
@ast
Metabolism and bioactivation o ...... ne kinase, in cancer patients.
@en
P2093
P2860
P356
P1476
Metabolism and bioactivation o ...... ne kinase, in cancer patients.
@en
P2093
Dafang Zhong
Haoyuan Jiang
Jialan Zhou
Lijia Zhang
Xiaoyan Chen
Xingxing Diao
Zhiwei Gao
P2860
P304
P356
10.1111/BPH.12047
P407
P577
2013-04-01T00:00:00Z